ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
200794-250MG |
|
NA |
(3aS,8aS)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(3,5-diisopropyl-4-methoxyphenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
250MG | C59H85O10P | |
200794-100MG |
|
NA |
(3aS,8aS)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(3,5-diisopropyl-4-methoxyphenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
100MG | C59H85O10P | |
200770-250MG |
|
NA |
(3aR,8aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(3,5-diisopropyl-4-methoxyphenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
250MG | C59H85O10P | |
200770-100MG |
|
NA |
(3aR,8aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(3,5-diisopropyl-4-methoxyphenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
100MG | C59H85O10P | |
200793-250MG |
|
NA |
(3aS,8aS)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(4-(tert-butyl)phenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
250MG | C47H61O6P | |
200793-100MG |
|
NA |
(3aS,8aS)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(4-(tert-butyl)phenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
100MG | C47H61O6P | |
200769-250MG |
|
NA |
(3aR,8aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(4-(tert-butyl)phenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
250MG | C47H61O6P | |
200769-100MG |
|
NA |
(3aR,8aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(4-(tert-butyl)phenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine ≥95%,99%e.e. |
100MG | C47H61O6P | |
200792-250MG |
|
NA |
(3aS,8aS)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetra-2-naphthalenyl-6-oxide-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin ≥95%,99%e.e. |
250MG | C47H37O6P | |
200792-100MG |
|
NA |
(3aS,8aS)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetra-2-naphthalenyl-6-oxide-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin ≥95%,99%e.e. |
100MG | C47H37O6P | |
200768-250MG |
|
952649-50-2 |
(3aR,8aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetra-2-naphthalenyl-6-oxide-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin ≥95%,99%e.e. |
250MG | C47H37O6P | |
200768-100MG |
|
952649-50-2 |
(3aR,8aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetra-2-naphthalenyl-6-oxide-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin ≥95%,99%e.e. |
100MG | C47H37O6P | |
200754-1G |
|
NA |
(5aS,10bR)- 2-Mesityl-8-bromo -5a,10b- ?dihydro-4H,?6H-?indeno[2,?1- ?b]?[1,?2,?4]?triazolo[4,?3- ?d][1,?4]?oxazinium Tetrafluoroborate ≥95%,99%e.e. |
1G | C21H21N3OBr·BF4 | |
200753-100MG |
|
NA |
(5aR,10bS)- 2-Mesityl-8-bromo -5a,10b- ?dihydro-4H,?6H-?indeno[2,?1- ?b]?[1,?2,?4]?triazolo[4,?3- ?d][1,?4]?oxazinium Tetrafluoroborate ≥95%,99%e.e. |
100MG | C21H21N3OBr·BF4 | |
200752-100MG |
|
NA |
(5aS,10bR)-2-Mesityl-8-nitro-5a,10b- dihydro-4H,6H-indeno[2,1- b][1,2,4]triazolo[4,3- d][1,4]oxazinium Tetrafluoroborate ≥95%,99%e.e. |
100MG | C21H21N4O3·BF4 | |
200751-100MG |
|
NA |
(5aR,10bS)-2-Mesityl-8-nitro-5a,10b- dihydro-4H,6H-indeno[2,1- b][1,2,4]triazolo[4,3- d][1,4]oxazinium Tetrafluoroborate ≥95%,99%e.e. |
100MG | C21H21N4O3·BF4 | |
200750-100MG |
|
NA |
(5aS,10bR)- 2-Mesityl-8-isopropyl-5a,10b- ?dihydro-4H,?6H-?indeno[2,?1- ?b]?[1,?2,?4]?triazolo[4,?3- ?d][1,4]oxazinium Tetrafluoroborate ≥95%,99%e.e. |
100MG | C24H28N3O·BF4 | |
200749-100MG |
|
NA |
(5aR10bS)- 2-Mesityl-8-isopropyl-5a,10b- ?dihydro-4H,?6H-?indeno[2,?1- ?b]?[1,?2,?4]?triazolo[4,?3- ?d][1,4]oxazinium Tetrafluoroborate ≥95%,99%e.e. |
100MG | C24H28N3O·BF4 | |
200746-100MG |
|
NA |
(5aS,10bR)-2-(Naphthalen-1-yl)-5a,10b- dihydro-4H,6H-indeno[2,1- b][1,2,4]triazolo[4,3- d][1,4]oxazinium Tetrafluoroborate ≥95%,99%e.e. |
100MG | C22H18N3O·BF4 | |
200745-100MG |
|
NA |
(5aR,10bS)-2-(Naphthalen-1-yl)-5a,10b- dihydro-4H,6H-indeno[2,1- b][1,2,4]triazolo[4,3- d][1,4]oxazinium Tetrafluoroborate ≥95%,99%e.e. |
100MG | C22H18N3O·BF4 | |